Martha Demski Biography and Net Worth

Director of Alpha Teknova

Martha J. Demski was appointed to Teknova’s Board of Directors as an independent director in August 2023. Since 2005 she has also served on the board of Chimerix, Inc., where she was Chair from June 2018 through July 2023, and is currently the Lead Independent Director and a member of the audit committee. She also currently serves on the board of Equillium, Inc. as chair of the audit committee and a member of the compensation committee. Her prior board experience includes her role as director for several life sciences companies, including Adamas Pharmaceuticals, Inc., ADMA Biologics, Inc., and Neothetics, Inc.; she chaired the audit committee and was a member of the compensation committee of all three companies. From 2011 to 2017, Ms. Demski served as Senior Vice President and Chief Financial Officer of Ajinimoto Althea, Inc., now known as Ajinomoto Bio-Pharma Services, a fully integrated contract development and manufacturing organization. From 2008 to 2010, she served as the Interim Chief Operating Officer and Chief Financial Officer of the Sidney Kimmel Cancer Center, a non-profit corporation that engaged in biomedical research. Earlier, Ms. Demski served as Vice President and Chief Financial Officer of Vical. She has more than 13 years of banking experience with Bank of America.

Ms. Demski is a National Association of Corporate Directors Board Governance Fellow, and she received the Director of the Year in Corporate Governance award by the Corporate Directors Forum in 2017. Ms. Demski earned her B.A. from Michigan State University and an MBA from The University of Chicago Booth School of Business with concentrations in accounting and finance.

What is Martha J. Demski's net worth?: The estimated net worth of Martha J. Demski is at least $57.96 thousand as of June 27th, 2025. Ms. Demski owns 12,000 shares of Alpha Teknova stock worth more than $57,960 as of December 5th. This net worth evaluation does not reflect any other assets that Ms. Demski may own. Learn More about Martha J. Demski's net worth.
How do I contact Martha J. Demski?: The corporate mailing address for Ms. Demski and other Alpha Teknova executives is , , . Alpha Teknova can also be reached via phone at 831-637-1100 and via email at [email protected]. Learn More on Martha J. Demski's contact information.
Has Martha J. Demski been buying or selling shares of Alpha Teknova?: Martha J. Demski has not been actively trading shares of Alpha Teknova during the last quarter. Most recently, Martha J. Demski sold 8,000 shares of the business's stock in a transaction on Friday, June 27th. The shares were sold at an average price of $5.06, for a transaction totalling $40,480.00. Following the completion of the sale, the director now directly owns 12,000 shares of the company's stock, valued at $60,720. Learn More on Martha J. Demski's trading history.
Who are Alpha Teknova's active insiders?: Alpha Teknova's insider roster includes Martha Demski (Director), Ken Gelhaus (Insider), Stephen Gunstream (CEO), Matthew Lowell (CFO), J. Mackowski (Director), and Damon Terrill (General Counsel). Learn More on Alpha Teknova's active insiders.
Are insiders buying or selling shares of Alpha Teknova?: In the last twelve months, insiders at the sold shares 1 times. They sold a total of 8,000 shares worth more than $40,480.00. The most recent insider tranaction occured on June, 27th when Director Martha J Demski sold 8,000 shares worth more than $40,480.00. Insiders at Alpha Teknova own 12.5% of the company. Learn More about insider trades at Alpha Teknova.
Information on this page was last updated on 6/27/2025.

Martha J. Demski Insider Trading History at Alpha Teknova

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
6/27/2025	Sell	8,000	$5.06	$40,480.00	12,000

Martha J. Demski Buying and Selling Activity at Alpha Teknova

Alpha Teknova Company Overview

Alpha Teknova, Inc. produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.

Today's Range

Now: $4.83

$4.70

$4.87

50 Day Range

MA: $5.09

$4.28

$6.37

2 Week Range

Now: $4.83

$3.94

$10.37

Volume

66,052 shs

Average Volume

166,336 shs

Market Capitalization

$258.55 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.4